Dr. Raj M. Baljepally, MD

Dr. Baljepally practices at The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical.

Dr. Baljepally's NPI, 1598766370, was assigned on August 3, 2005. Dr. Baljepally graduated from Gandhi Medical College in 1989. Dr. Baljepally holds Tennessee license 31098.

Dr. Baljepally's primary practice is The University of Tennessee Medical Center, at 1924 Alcoa Highway, Knoxville, TN 37920 in Knox County. The practice phone is (865) 305-9000.

Dr. Baljepally's primary practice is The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical. Dr. Baljepally is also affiliated with Covenant Health Fort Loudoun. The medical group on file is UT Internal Medicine - Pellissippi. Dmand AI also links Dr. Baljepally to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baljepally practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Baljepally's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Baljepally is board certified in cardiovascular disease by the National Board of Physicians and Surgeons. Dr. Baljepally is licensed in Tennessee.

Dmand AI lists angioplasty, cardiac catheterization and circulation problems among the conditions Dr. Baljepally treats.

CMS data shows 1,228 Medicare services from Dr. Baljepally across 22 procedure codes in 2024, for 697 Medicare patients. Medicare paid $80,737 for them.

CMS counts 697 Medicare patients who saw Dr. Baljepally in 2024. The largest group is 75 to 84, with 283 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baljepally's median patient age at 74, with 46% women.

In 2024, Dr. Baljepally wrote 1,157 Medicare Part D claims for 246 patients. 80% of them were for generic drugs. CMS names the drug for 1,037 of them, across 24 drugs with 11 or more claims each, at $248,872 in total drug cost. In 2023, CMS named 1,570 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Baljepally for performance year 2024, reported through an alternative payment model (APM). Dr. Baljepally accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 42 procedures of coronary angioplasty and stenting by Dr. Baljepally, more than 78% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Baljepally, published from 2017 to 2025. 2021 was the busiest year, with 15. The most frequent topics are Cardiac Catheterization, Coronary Angiography and Electrocardiography. Dr. Baljepally has published most often in Cardiol Res. Dr. Baljepally's most frequent co-authors are James Eugene Livesay, DO, Hassan Tahir, MD and Chirag J. Patel, MD.

Dmand AI links Dr. Baljepally to 1 clinical trial. Conditions studied include Mitral Valve Insufficiency and Heart Valve Diseases.

CMS Open Payments shows 586 general payments to Dr. Baljepally from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Boston Scientific Corporation paid the most, $2,981.

Dmand AI lists 3 awards for Dr. Baljepally, most recently Excellence in Clinical Research Award in 2022.

Dr. Baljepally graduated from Gandhi Medical College in 1989. Dr. Baljepally is a member of ACC and American Society of Cardiac Angiography and Internation.

Dr. Baljepally is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.